Electronic fetal monitoring as a public health screening program: the arithmetic of failure
- PMID: 21099609
- DOI: 10.1097/AOG.0b013e3181fae39f
Electronic fetal monitoring as a public health screening program: the arithmetic of failure
Abstract
Electronic fetal monitoring has failed as a public health screening program. Nevertheless, most of the four million low-risk women giving birth in the United States each year continue to undergo this screening. The failure of this program should have been anticipated and thus avoided had the accepted principles of screening been considered before its introduction. All screening tests have poor positive predictive value when searching for rare conditions such as fetal death in labor or cerebral palsy. This problem is aggravated when the screening test does not have good validity as is the case with electronic fetal monitoring. Because of low-prevalence target conditions and mediocre validity, the positive predictive value of electronic fetal monitoring for fetal death in labor or cerebral palsy is near zero. Stated alternatively, almost every positive test result is wrong. To avoid such costly errors in the future, the prerequisites for any screening program must be fulfilled before the program is begun.
Comment in
-
Electronic fetal monitoring as a public health screening program: the arithmetic of failure.Obstet Gynecol. 2011 Mar;117(3):730. doi: 10.1097/AOG.0b013e31820dbe16. Obstet Gynecol. 2011. PMID: 21343780 No abstract available.
-
Electronic fetal monitoring as a public health screening program: the arithmetic of failure.Obstet Gynecol. 2011 Mar;117(3):731. doi: 10.1097/AOG.0b013e31820e2feb. Obstet Gynecol. 2011. PMID: 21343782 No abstract available.
-
Electronic fetal monitoring as a public health screening program: the arithmetic of failure [corrected].Obstet Gynecol. 2011 Apr;117(4):986. doi: 10.1097/AOG.0b013e318212ecc8. Obstet Gynecol. 2011. PMID: 21422874 No abstract available.
References
-
- Law M. Screening without evidence of efficacy. BMJ 2004;328:301–2.
-
- Lent M. The medical and legal risks of the electronic fetal monitor. Stanford Law Rev 1999;51:807–37.
-
- Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G. Communicating accuracy of tests to general practitioners: a controlled study. BMJ 2002;324:824–6.
-
- Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881–4.
-
- Martin DH, Cammarata C, Van Der Pol B, Jones RB, Quinn TC, Gaydos CA, et al. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol 2000;38:3544–9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
